NYSE: ANVS
Annovis Bio Inc Stock Ownership - Who owns Annovis Bio?

Insider buying vs selling

Have Annovis Bio Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael B. HoffmanDirector2026-05-202,562$1.75
$4.48kBuy
Michael B. HoffmanDirector2026-05-2018,849$1.80
$33.93kBuy
Michael B. HoffmanDirector2026-05-2054,933$1.90
$104.37kBuy
Michael B. HoffmanDirector2026-04-02713,800$2.10
$1.50MBuy
Michael B. HoffmanDirector2025-12-0815,000$4.24
$63.60kBuy
Michael B. HoffmanDirector2025-12-0830,000$4.34
$130.20kBuy
Michael B. HoffmanDirector2025-11-24415$4.14
$1.72kBuy
Michael B. HoffmanDirector2025-11-2428,096$4.15
$116.60kBuy
Michael B. HoffmanDirector2025-11-249,200$3.85
$35.42kBuy
Michael B. HoffmanDirector2025-11-241,489$4.13
$6.15kBuy

1 of 2

ANVS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ANVS insiders and whales buy or sell their stock.

ANVS Shareholders

What type of owners hold Annovis Bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Michael B. Hoffman8.95%3,811,597$3.89MInsider
Marialuisa MacCecchini2.84%1,212,020$1.24MInsider
Jr Robert M. Whelan0.22%95,700$97.61kInsider
Mark K. White0.14%61,167$62.39kInsider
Jeffrey Brian McGroarty0.12%52,833$53.89kInsider
Claudine Bruck0.03%13,709$13.98kInsider
Reid McCarthy0.02%9,305$9.49kInsider
Empery Asset Management LP0.01%2,401$2.45kInstitution
Empery0.01%2,401$2.45kInstitution
Marwac0.00%1,842$1.88kInstitution

1 of 3

ANVS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ANVS0.03%12.34%Net Buying
INMB0.02%26.79%Net Buying
DWTX0.01%96.00%Net BuyingNet Buying
BMEA0.03%25.13%Net Buying
APLM0.00%80.25%Net BuyingNet Buying

Annovis Bio Stock Ownership FAQ

Who owns Annovis Bio?

Annovis Bio (NYSE: ANVS) is owned by 0.03% institutional shareholders, 12.34% Annovis Bio insiders, and 87.63% retail investors. Michael B. Hoffman is the largest individual Annovis Bio shareholder, owning 3.81M shares representing 8.95% of the company. Michael B. Hoffman's Annovis Bio shares are currently valued at $3.89M.

If you're new to stock investing, here's how to buy Annovis Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.